Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countries
Weight-loss jabs such as Wegovy and Ozempic could be made for just $3 a month, according to new analysis, potentially making the treatment available to millions in poorer countries as patents expire.
More than a billion people live with obesity worldwide, with rates rising fast in lower-income nations as they shift to westernised diets and more sedentary lifestyles.
The World Health Organization designated semaglutide – sold to treat obesity under the brand name Wegovy, and diabetes under the brand name Ozempic – as an essential medicine in September last year.
Plus the fact that we just won’t eat our greens and exercise enough.
And many people frankly can’t. There are a lot of complex socioeconomical reasons so many people are obese. If it were just a matter of will power, it wouldn’t effect a billion people